Trial intelligence / Profile preview

Propranolol for Chronic PTSD Reconsolidation

NCT01127568Phase 3Unknown

Sponsor
Douglas Mental Health University Institute
Start
Feb 2010
Primary completion
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of propranolol in post-traumatic stress disorder (PTSD), sponsored by Douglas Mental Health University Institute. Status: unknown.

02

Drugs

propranolol
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT01127568.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01127568.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call